Skip to search formSkip to main contentSkip to account menu

AV 412

Known as: AV-412, AV412 cpd 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

MP 412

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Phase I study of AV-412, a novel, irreversible EGFR inhibitor, administered intermittently in patients with advanced solid tumors.
3103 Background: AV-412, an irreversible EGFR TKI, has demonstrated activity in chimeric mouse models bearing the L858R/T790M… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)